COVID-19: EFPIA and IFPMA-PhRMA ethical guidance

During the COVID-19 pandemic, EFPIA and its members remained fully committed to EFPIA Code requirements. We have continued implementing and applying the highest ethical standards as well as applicable laws and regulations such as competition, data protection, anti-bribery and anti-corruption legislation.

The EFPIA ethical principles have helped in assessing urgently the appropriateness of activities:
- Patients first
- Integrity
- Respect
- Transparency

Nevertheless, the COVID-19 pandemic has directly impacted the transposition of the EFPIA Code in the national Codes and the disclosure provisions. Therefore, EFPIA has drafted guidance to extend certain time periods in relation to meeting commitments relevant to these two specific topics.

Due to the lockdown, the interactions and activities that are needed to maintain the scientific exchange, have moved to virtual to protect the health and safety of patients and healthcare professionals. In addition to maintaining the EFPIA, IFPMA, and PhRMA Codes of Practice standards in virtual settings. The 3 organisations have decided, for the first time, to jointly issue guidance on Virtual International Medical Congresses impacted by COVID-19, which will be in effect until December 31, 2020. Besides this joint guidance, EFPIA guidance includes the decision endorsed by the EFPIA members in May to prohibit the provision of meals for the healthcare professionals attending individually a virtual congress.